Help us #STOPTHEBOP and protect access to these irreplaceable treatments by signing our petition now
Clinical studies show Tirzepatide can lead to significant weight loss for many individuals
Melatonin treatment has downregulated and upregulated CDK1 and p21 in GC cell lines, respectively [165]
That particular study found that at the 86-week mark, most if not all participants had put back all of their lost weight except for 3 pounds
GLP-1RA or dual GIP/GLP-1RA added to basal insulin compared to basal insulin titrated with a rigorous intention-to-treat approach is moderately effective in preventing further increase in daily basal insulin dose from achieving treat-to-target glycemic goals ( daily insulin dose, SMD -0.49, 95% CI -0.71
However, it could be worth switching medications, to see if your body reacts differently to another type